Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait

Clin Immunol. 2012 Jun;143(3):266-72. doi: 10.1016/j.clim.2012.03.002. Epub 2012 Mar 30.

Abstract

Deficiency of dedicator of cytokinesis 8 (DOCK8) is a newly described combined primary immunodeficiency disease. It was found to account for 15% of combined immune deficiency cases in the National Primary Immunodeficiency Disorders Registry in Kuwait, a country with high prevalence of consanguinity. We present the clinical, immunologic and molecular characteristics of 9 Kuwaiti patients with DOCK8 deficiency and discuss differences that distinguish DOCK8 deficiency from atopic dermatitis. Clinical immunologists in areas with high incidence of consanguinity should have a high index of suspicion of DOCK8 deficiency in children with recalcitrant eczema, recurrent non-cutaneous infections and lymphopenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism
  • Bacterial Infections / immunology
  • Child
  • Child, Preschool
  • Cytokines / biosynthesis
  • Cytokines / immunology
  • Female
  • Guanine Nucleotide Exchange Factors / deficiency*
  • Guanine Nucleotide Exchange Factors / genetics
  • Guanine Nucleotide Exchange Factors / immunology
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunoglobulins / blood
  • Immunoglobulins / immunology
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Deficiency Syndromes / genetics
  • Immunologic Deficiency Syndromes / immunology*
  • Infant
  • Kuwait
  • Leukocytes, Mononuclear / immunology
  • Leukocytes, Mononuclear / metabolism
  • Lymphocyte Activation / immunology
  • Male
  • Mutation
  • Mycoses / immunology
  • T-Lymphocytes / immunology
  • Treatment Outcome
  • Virus Diseases / immunology

Substances

  • Anti-Bacterial Agents
  • Cytokines
  • DOCK8 protein, human
  • Guanine Nucleotide Exchange Factors
  • Immunoglobulins
  • Immunoglobulins, Intravenous